BSE Live
Jan 01, 16:00Prev. Close
0.75
Open Price
0.84
Bid Price (Qty.)
0.75 (12330)
Offer Price (Qty.)
0.76 (157723)
NSE Live
Prev. Close
Open Price
Bid Price (Qty.)
()
Offer Price (Qty.)
()
| Key Financial Ratios of Remedium Lifecare (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 11 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 1.63 | 0.07 | -0.02 | 0.05 | -0.99 | |
| Diluted EPS (Rs.) | 1.63 | 0.07 | -0.02 | 0.05 | -0.99 | |
| Cash EPS (Rs.) | 1.66 | 0.15 | 0.06 | 0.33 | -0.96 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 8.43 | 6.79 | 6.72 | 6.73 | 6.68 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 8.43 | 6.79 | 6.72 | 6.73 | 6.68 | |
| Dividend / Share(Rs.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Revenue from Operations/Share (Rs.) | 5.89 | 7.30 | 7.23 | 6.38 | 5.63 | |
| PBDIT/Share (Rs.) | 2.06 | 0.20 | 0.07 | 0.35 | -0.90 | |
| PBIT/Share (Rs.) | 2.02 | 0.11 | -0.01 | 0.07 | -0.94 | |
| PBT/Share (Rs.) | 2.02 | 0.11 | -0.02 | 0.06 | -0.98 | |
| Net Profit/Share (Rs.) | 1.63 | 0.07 | -0.02 | 0.05 | -0.99 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 34.96 | 2.68 | 0.93 | 5.49 | -16.03 | |
| PBIT Margin (%) | 34.40 | 1.54 | -0.20 | 1.03 | -16.62 | |
| PBT Margin (%) | 34.36 | 1.50 | -0.24 | 0.97 | -17.48 | |
| Net Profit Margin (%) | 27.67 | 0.98 | -0.24 | 0.79 | -17.64 | |
| Return on Networth / Equity (%) | 19.31 | 1.05 | -0.26 | 0.74 | -14.86 | |
| Return on Capital Employed (%) | 18.67 | 0.92 | -0.24 | 0.64 | -12.82 | |
| Return on Assets (%) | 10.04 | 0.35 | -0.10 | 0.31 | -7.71 | |
| Total Debt/Equity (X) | 0.03 | 0.14 | 0.10 | 0.16 | 0.16 | |
| Asset Turnover Ratio (%) | 36.30 | 35.92 | 42.23 | 40.29 | 43.68 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.24 | 1.02 | 1.15 | 1.35 | 1.43 | |
| Quick Ratio (X) | 0.74 | 0.59 | 0.61 | 0.74 | 0.44 | |
| Inventory Turnover Ratio (X) | 1.59 | 1.37 | 1.37 | 1.30 | 1.10 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 100.00 | 100.00 | 0.00 | 100.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 100.00 | 100.00 | 0.00 | 100.00 | 0.00 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 100.00 | 100.00 | 0.00 | 100.00 | 0.00 | |
| Price/BV (X) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
27.11.2025
Remedium Lifeca Standalone September 2025 Net Sales at Rs 8.58 crore, down 65.8% Y-o-Y
05.08.2025
Remedium Lifeca Standalone June 2025 Net Sales at Rs 18.37 crore, down 76.35% Y-o-Y
24.06.2025
Remedium Lifeca Standalone March 2025 Net Sales at Rs 81.57 crore, down 94.21% Y-o-Y
26.11.2024
Remedium Lifeca Standalone September 2024 Net Sales at Rs 25.08 crore, down 94.65% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017